Delivery Order SPE2DB24D8003-SPE2DB24FJTDR
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen. The $3,869.65 contract has a completion date of July 2, 2025 and is not a set-aside award. Dakota Drug, Inc. is a key supplier of medical products and pharmaceuticals to the U.S. Armed Forces, having been awarded a $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,500.92 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML medical supplies. This award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date of March 11,...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a Delivery Order valued at $2,397.84 for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 16, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly supporting U.S. Armed...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,844.88 firm fixed price delivery order is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025 and is not set aside. It is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a total ceiling value of $1,188.84 and a period of performance through May 28, 2025. Dakota Drug, Inc. is a key supplier of medical products and pharmaceuticals to the U.S. Armed Forces, holding a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,215.04 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a completion date of May 30, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,172.90 and a period of performance through October 18, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,377.68 and a performance period through April 7, 2025. It is a Firm Fixed Price contract and is not set-aside. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...